Attila Nakeeb
Appearances
- DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
Indiana University School of MedicineIndiana University - DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
Indiana UniversityIndiana University School of Medicine - DateMay 19, 2024BACKGROUND: Accurate clinical staging plays a key role in the multimodal treatment of pancreatic ductal adenocarcinoma (PDAC)…
Presenter
Speakers
Indiana UniversityIndiana University School of Medicine - DateMay 19, 2024BACKGROUND: Historical pediatric data recommend surgical resection for type I choledochal cysts due to the risk of malignant progression over time up to 30%…
Presenter
Speakers
Indiana University School of MedicineIndiana University GOBLET CELL ADENOCARCINOMA AND RESPONSE TO TREATMENT - SINGLE CENTER EXPERIENCE OF A RARE MALIGNANCY
DateMay 21, 2024Goblet cell adenocarcinoma is a rare malignancy with an incidence of 1 per 2 million people worldwide…Presenter
Speakers
Indiana UniversityIndiana University School of Medicine
